Enterococcus faecium stimulates human neutrophils via the formyl-peptide receptor 2

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Bloes, Dominik Alexander ^a   Otto, Michael ^b   Peschel, Andreas ^a   Kretschmer, Dorothee ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CALCIUM ION; COMPLEMENT RECEPTOR; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR 2; PHENOL SOLUBLE MODULIN; UNCLASSIFIED DRUG; VANCOMYCIN;

AMINO ACID SEQUENCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CALCIUM TRANSPORT; CELL STRAIN HL 60; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; GENETIC TRANSFECTION; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKOCYTE ACTIVATION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHYSICAL CHEMISTRY; PROTEIN SECRETION; RECEPTOR UPREGULATION; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE; STREPTOCOCCUS AGALACTIAE; VANCOMYCIN RESISTANT ENTEROCOCCUS; YERSINIA ENTEROCOLITICA; YERSINIA PSEUDOTUBERCULOSIS;

BACTERIAL TOXINS; CALCIUM; CHEMOTAXIS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FECES; HL-60 CELLS; HUMANS; IONS; NEUTROPHILS; PEPTIDES; PROTEOLYSIS; RECEPTORS, COMPLEMENT; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; STAPHYLOCOCCUS; TRANSFECTION; UP-REGULATION;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS;

EID: 84863098329     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039910     Document Type: Article

References (45)

1. Medzhitov R, (2007) Recognition of microorganisms and activation of the immune response. Nature 449: 819-826.
2. Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, et al. (2009) International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 61: 119-161.
3. Marasco WA, Phan SH, Krutzsch H, Showell HJ, Feltner DE, et al. (1984) Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J Biol Chem 259: 5430-5439.
4. Migeotte I, Communi D, Parmentier M, (2006) Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev 17: 501-519.
5. Kretschmer D, Gleske AK, Rautenberg M, Wang R, Koberle M, et al. (2010) Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe 7: 463-473.
6. Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, et al. (2007) Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 13: 1510-1514.
7. Prat C, Bestebroer J, de Haas CJ, van Strijp JA, van Kessel KP, (2006) A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1. J Immunol 177: 8017-8026.
8. Rautenberg M, Joo HS, Otto M, Peschel A, (2011) Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulence. FASEB J 25: 1254-1263.
9. Sava IG, Heikens E, Huebner J, (2010) Pathogenesis and immunity in enterococcal infections. Clin Microbiol Infect 16: 533-540.
10. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, et al. (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 29: 996-1011.
11. Arias CA, Murray BE, (2012) The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 10: 266-278.
12. Hirt H, Schlievert PM, Dunny GM, (2002) In vivo induction of virulence and antibiotic resistance transfer in Enterococcus faecalis mediated by the sex pheromone-sensing system of pCF10. Infect Immun 70: 716-723.
13. Chow JW, Thal LA, Perri MB, Vazquez JA, Donabedian SM, et al. (1993) Plasmid-associated hemolysin and aggregation substance production contribute to virulence in experimental enterococcal endocarditis. Antimicrob Agents Chemother 37: 2474-2477.
14. Schlievert PM, Gahr PJ, Assimacopoulos AP, Dinges MM, Stoehr JA, et al. (1998) Aggregation and binding substances enhance pathogenicity in rabbit models of Enterococcus faecalis endocarditis. Infect Immun 66: 218-223.
15. Sannomiya P, Craig RA, Clewell DB, Suzuki A, Fujino M, et al. (1990) Characterization of a class of nonformylated Enterococcus faecalis-derived neutrophil chemotactic peptides: the sex pheromones. Proc Natl Acad Sci U S A 87: 66-70.
16. Ember JA, Hugli TE, (1989) Characterization of the human neutrophil response to sex pheromones from Streptococcus faecalis. Am J Pathol 134: 797-805.
17. Wirth R, (1994) The sex pheromone system of Enterococcus faecalis. More than just a plasmid-collection mechanism? Eur J Biochem 222: 235-246.
18. Schulte B, Heininger A, Autenrieth IB, Wolz C, (2008) Emergence of increasing linezolid-resistance in enterococci in a post-outbreak situation with vancomycin-resistant Enterococcus faecium. Epidemiol Infect 136: 1131-1133.
19. Christophe T, Karlsson A, Dugave C, Rabiet MJ, Boulay F, et al. (2001) The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J Biol Chem 276: 21585-21593.
20. Dahlgren C, Christophe T, Boulay F, Madianos PN, Rabiet MJ, et al. (2000) The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor. Blood 95: 1810-1818.
21. Durr MC, Kristian SA, Otto M, Matteoli G, Margolis PS, et al. (2006) Neutrophil chemotaxis by pathogen-associated molecular patterns-formylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus. Cell Microbiol 8: 207-217.
22. Marasco WA, Phan SH, Krutzsch H, Showell HJ, Feltner DE, et al. (1984) Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J Biol Chem 259: 5430-5439.
23. Fu H, Karlsson J, Bylund J, Movitz C, Karlsson A, et al. (2006) Ligand recognition and activation of formyl peptide receptors in neutrophils. J Leukoc Biol 79: 247-256.
24. Le Y, Murphy PM, Wang JM, (2002) Formyl-peptide receptors revisited. Trends Immunol 23: 541-548.
25. Nanamori M, Cheng X, Mei J, Sang H, Xuan Y, et al. (2004) A novel nonpeptide ligand for formyl peptide receptor-like 1. Mol Pharmacol 66: 1213-1222.
26. Kretschmer D, Nikola N, Durr M, Otto M, Peschel A, (2012) The virulence regulator Agr controls the staphylococcal capacity to activate human neutrophils via the formyl peptide receptor 2. J Innate Immun 4: 201-212.
27. Schiffmann E, Corcoran BA, Wahl SM, (1975) N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci U S A 72: 1059-1062.
28. Mader D, Rabiet MJ, Boulay F, Peschel A, (2010) Formyl peptide receptor-mediated proinflammatory consequences of peptide deformylase inhibition in Staphylococcus aureus. Microbes Infect 12: 415-419.
29. Prat C, Haas PJ, Bestebroer J, de Haas CJ, van Strijp JA, et al. (2009) A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR. J Immunol 183: 6569-6578.
30. Wiseman GM, (1975) The hemolysins of Staphylococcus aureus. Bacteriol Rev 39: 317-344.
31. Cheung GY, Duong AC, Otto M, (2012) Direct and synergistic hemolysis caused by Staphylococcus phenol-soluble modulins: implications for diagnosis and pathogenesis. Microbes Infect 14: 380-386.
32. Passerini R, Ghezzi T, Sandri M, Radice D, Biffi R, (2011) Ten-year surveillance of nosocomial bloodstream infections: trends of aetiology and antimicrobial resistance in a comprehensive cancer centre. Ecancermedicalscience 5: 191.
33. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, et al. (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39: 309-317.
34. Holtfreter S, Jursa-Kulesza J, Masiuk H, Verkaik NJ, de Vogel C, et al. (2011) Antibody responses in furunculosis patients vaccinated with autologous formalin-killed Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 30: 707-717.
35. Verkaik NJ, Dauwalder O, Antri K, Boubekri I, de Vogel CP, et al. (2010) Immunogenicity of toxins during Staphylococcus aureus infection. Clin Infect Dis 50: 61-68.
36. Periasamy S, Joo HS, Duong AC, Bach TH, Tan VY, et al. (2012) How Staphylococcus aureus biofilms develop their characteristic structure. Proc Natl Acad Sci U S A 109: 1281-1286.
37. Queck SY, Jameson-Lee M, Villaruz AE, Bach TH, Khan BA, et al. (2008) RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol Cell 32: 150-158.
38. Queck SY, Khan BA, Wang R, Bach TH, Kretschmer D, et al. (2009) Mobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSA. PLoS Pathog 5: e1000533.
39. Clewell DB, (1993) Sex pheromones and the plasmid-encoded mating response in Enterococcus faecalis. In: Clewell DB, editors. pp. 349-367 editor. Bacterial Conjugation: Plenum Press, New York. pp.
40. Sahm DF, Kissinger J, Gilmore MS, Murray PR, Mulder R, et al. (1989) In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 33: 1588-1591.
41. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, et al. (2006) Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367: 731-739.
42. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, et al. (2002) Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359: 1819-1827.
43. Werth N, Beerlage C, Rosenberger C, Yazdi AS, Edelmann M, et al. (2010) Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS One 5: e11576.
44. Heesemann J, Laufs R, (1983) Construction of a mobilizable Yersinia enterocolitica virulence plasmid. J Bacteriol 155: 761-767.
45. Tsubokura M, Aleksic S, Fukushima H, Schulze G, Someya K, et al. (1993) Characterization of Yersinia pseudotuberculosis serogroups O9, O10 and O11; subdivision of O1 serogroup into O1a, O1b, and O1c subgroups. Zentralbl Bakteriol 278: 500-509.